Razif Gabdoulline

Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML

Felicitas Thol, Razif Gabdoulline, Alessandro Liebich et al. · Blood · 2018 · 293 citations · Full text

Simulation of the diffusional association of barnase and barstar

Razif Gabdoulline, Rebecca C. Wade · Biophysical Journal · 1997 · 276 citations · Full text

Diffusion Resistance, Diffusion Process, Anomalous Diffusion +3

Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo

Anuhar Chaturvedi, Lena Herbst, Stefan Pusch et al. · Leukemia · 2017 · 117 citations · Full text

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +8

Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations

Michael Heuser, Bennet Heida, Konstantin Büttner et al. · Blood Advances · 2021 · 114 citations · Full text

Mrd Positivity, Engineering, Mixed-phenotype Acute Leukemia +18

Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation

Michael Heuser, Razif Gabdoulline, Patrick Löffeld et al. · Annals of Hematology · 2017 · 57 citations · Full text

Hematological Malignancy, Individual Outcome Prediction, Transplantation +10